| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
dicer 1, ribonuclease III | 0.446 | 0.846 | 1.00 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2017 | ||||||||
|
host cell factor C1 | 0.601 | 0.692 | 1.00 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.540 | None | 1.000 | 1 | 0 | 1997 | 2016 | ||||||||
|
ASH1 like histone lysine methyltransferase | 0.623 | 0.577 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 1994 | 2020 | ||||||||
|
DNA topoisomerase I | 0.542 | 0.692 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
trio Rho guanine nucleotide exchange factor | 0.556 | 0.731 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
nuclear receptor corepressor 1 | 0.597 | 0.731 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.400 | None | 1.000 | 2 | 0 | 1998 | 2020 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
group | 0.400 | None | 1.000 | 2 | 0 | 1994 | 2019 | ||||||||
|
dipeptidyl peptidase like 10 | 0.695 | 0.577 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 2003 | 2015 | ||||||||
|
BTB domain containing 11 | 0.839 | 0.192 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
protein kinase C epsilon | 0.597 | 0.692 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
transcription factor 4 | 0.464 | 0.846 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
TOX high mobility group box family member 3 | 0.636 | 0.538 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
hepatocyte growth factor | 0.374 | 0.885 | 1.00 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 1994 | 2019 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
group | 0.360 | None | 1.000 | 1 | 0 | 1995 | 2017 | ||||||||
|
transmembrane protein 132D | 0.617 | 0.692 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
glutamate ionotropic receptor kainate type subunit 2 | 0.561 | 0.769 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.600 | None | 1.000 | 2 | 0 | 1985 | 2019 | ||||||||
|
prickle planar cell polarity protein 2 | 0.711 | 0.423 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
BRCA1 associated protein 1 | 0.454 | 0.731 | 0.99 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
group | 0.340 | None | 1.000 | 1 | 0 | 1998 | 2016 |